GetTopicDetailResponse(id=ecc4153500b, topicName=Resmetirom, introduction=Resmetirom, content=null, image=null, comments=0, allHits=1334, url=https://h5.medsci.cn/topic?id=15350, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=96656, tagList=[TagDto(tagId=96656, tagName=Resmetirom)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2194501, encodeId=69ad2194501e8, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a> <a href='/topic/show?id=a36b2541439' target=_blank style='color:#2F92EE;'>#代謝功能障礙#</a> <a href='/topic/show?id=ecc4153500b' target=_blank style='color:#2F92EE;'>#Resmetirom#</a>, objectTitle=Nature：對(duì)抗代謝功能障礙相關(guān)的脂肪性肝炎(MASH)：全球數(shù)百萬(wàn)患者治療的新選擇, objectType=article, longId=817647, objectId=6c3681e64798, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-a-medical-recipe-P8LEKCP.jpg, objectUrl=/article/show_article.do?id=6c3681e64798, replyNumber=0, likeNumber=146, createdTime=2024-03-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6c3681e64798, moduleTitle=Nature：對(duì)抗代謝功能障礙相關(guān)的脂肪性肝炎(MASH)：全球數(shù)百萬(wàn)患者治療的新選擇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6c3681e64798)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193364, encodeId=0ce0219336466, content=<a href='/topic/show?id=3f60112310f4' target=_blank style='color:#2F92EE;'>#代謝功能障礙相關(guān)的脂肪性肝病#</a> <a href='/topic/show?id=7333112311d1' target=_blank style='color:#2F92EE;'>#MASH#</a> <a href='/topic/show?id=ecc4153500b' target=_blank style='color:#2F92EE;'>#Resmetirom#</a>, objectTitle=重大突破！全球首款代謝功能障礙相關(guān)的脂肪性肝?。∕ASLD）藥物獲批!, objectType=article, longId=817160, objectId=581881e16055, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240305/e006b27987fc488d91d035ce9df60779-5BDvRgMBpBux.jpg, objectUrl=/article/show_article.do?id=581881e16055, replyNumber=0, likeNumber=82, createdTime=2024-03-15, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=581881e16055, moduleTitle=重大突破！全球首款代謝功能障礙相關(guān)的脂肪性肝病（MASLD）藥物獲批!, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=581881e16055)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187267, encodeId=3dde218e26734, content=<a href='/topic/show?id=2fdc99e222d' target=_blank style='color:#2F92EE;'>#非酒精性脂肪性肝炎#</a> <a href='/topic/show?id=ecc4153500b' target=_blank style='color:#2F92EE;'>#Resmetirom#</a>, objectTitle=NEJM：Resmetirom有望成為非酒精性脂肪性肝炎突破性療法, objectType=article, longId=813351, objectId=271181335118, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=271181335118, replyNumber=0, likeNumber=134, createdTime=2024-02-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=271181335118, moduleTitle=NEJM：Resmetirom有望成為非酒精性脂肪性肝炎突破性療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=271181335118)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
